← Eichor
Study identifier: NCT07317245 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

HUmanitas PROtontherapy (HU-PRO)

Condition: Cancer · Proton Therapy  ·  Sponsor: Istituto Clinico Humanitas

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Proton therapy is a cancer treatment, similar to the more commonly used radiation therapy. It uses radiation to destroy cancer cells and helps control the disease in the treated area. However, when proton therapy is compared with standard radiation therapy, many studies show fewer side effects and better disease control. This is due to the unique physical properties of the particles used in proton therapy. At present, in Italy, this innovative treatment is available only for selected diseases, as defined by national guidelines. For this reason, it is very important to collect as much data as possible to support the further development of proton therapy and to improve treatment safety and effectiveness.

This description comes directly from the study's public registry record.

Talk to the study team

Marta Scorsetti, MD, radiation oncologist  ·  +39 0282248524  ·  marta.scorsetti@hunimed.eu

Davide Franceschini, MD, radiation oncologist  ·  +39 0282247428  ·  davide.franceschini@cancercenter.humanitas.it

Always discuss trial participation with your own doctor first.

Locations (1)

IRCCS Humanitas Research HospitalRozzano, Michigan, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07317245